ABC | Volume 110, Nº3, March 2018

Review Article Ket et al Practical Implications of Myocardial Viability Studies Arq Bras Cardiol. 2018; 110(3):278-288 13. Selvanayagam JB, Jerosch-Herold M, Porto I, Sheridan D, Cheng AS, Petersen SE, et al. Resting myocardial blood flow is impaired in hibernating myocardium: a magnetic resonance study of quantitative perfusion assessment. Circulation. 2005;112(21):3289-96. 14. Conversano A, Walsh JF, Geltman EM, Perez JE, Bergmann SR, Gropler RJ. Delineation of myocardial stunning and hibernation by positron emission tomography in advanced coronary artery disease. Am Heart J. 1996;131(3):440-50. 15. Canty JM Jr, Fallavollita JA. Hibernating myocardium. J Nucl Med. 2005;12(1):104-19. 16. Vanoverschelde JL,WijnsW,BorgersM,HeyndrickxG,Depr C,FlamengW, et al. Chronic myocardial hibernation in humans: from bedside to bench. Circulation. 1997;95(7):1961-71. 17. Bax JJ, Visser FC, Poldermans D, Elhendy A, Cornel JH, Boersma E, et al. Time course of functional recovery of stunned and hibernating segments after surgical revascularization. Circulation. 2001;104(12 Suppl 1):I314-8. 18. Arai AE. Myocardial infarction and viability with an emphasis on imaging delayed enhancement. In: Kwong RY. (ed.). Cardiovascular magnetic resonance imaging. Totowa (NJ): Humana Press Inc; 2008. p. 351-75. 19. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testingand impactofrevascularizationonprognosis inpatientswithcoronary artery disease and left ventricular dysfunction: a meta-analysis. J Nucl Cardiol. 2002;39(7):1151-8. 20. Pierard LA, De Landsheere CM, Berthe C, Rigo P, Kulbertus HE. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol. 1990;15(5):1021-3. 21. Picano E, MathiasW Jr, Pingitore A, Bigi R, Previtali M. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicenter study. Lancet. 1994;344(8931):1190-2. 22. Cortigiani L, Bigi R, Gigli G, Coletta C, Mariotti E, Dodi C, et al. Prognostic implications of intraventricular conduction defects in patients undergoing stress echocardiography for suspected coronary artery disease. Am J Med. 2003;115(1):12-8. 23. Salustri A, Elhendy A, Garyfallidis P, Ciavatti M, Cornel JH, ten Cate FJ, et al. Prediction of improvement of ventricular function after acute myocardial infarction using low-dose dobutamine stress echocardiography. Am J Cardiol. 1994;74(9):853-6. 24. Elhendy A, Trocino G, Salustri A, Cornel JH, Roelandt JR, Boersma E, et al. Low-dose dobutamine echocardiography and rest-redistribution thallium-201 tomography in the assessment of spontaneous recovery of left ventricular function after recent myocardial infarction. Am Heart J. 1996;131(6):1088-96. 25. Marzullo P, Parodi O, Reisenhofer B, Sambuceti G, Picano E, Distante A, et al. Value of rest – thallium-201/technetium-99 sestamibi and dobutamine echocardiography for detecting myocardial viability. Am J Cardiol. 1993;71(2):166-72. 26. Schinkel AF, Poldermans D, Elhendy A, Bax JJ. Assessment of myocardial viability in patients with heart failure. J Nucl Med. 2007;48(7):1135-46. 27. Giogetti A, Marzullo P, Sambuceti G, Di Quirico S, Kusch A, Landi P, et al; Baseline/postnitrate Tc-99m tetrofosmin mismatch for the assessment of myocardial viability in patients with severe left ventricular dysfunction: comparison with baseline Tc-99m tetrofosmin scintigraphy/FDG PET imaging. J Nucl Cardiol. 2004;11(12):142-51. 28. Schinkel AF, Bax JJ, Poldermans D, Elhendy A, Ferrari R, Rahimtoola SH. Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol. 2007;32(7):375-410. 29. SciagraR,PellegriM,PupiA,BologneseL,BisiG,CarnovaleV,etal.Prognostic implicationsofTc-99msestamibiviability imagingandsubsequenttherapeutic strategy in patients with chronic coronary artery disease and left ventricular dysfunction. J AmColl Cardiol. 2000;36(3):739-45. 30. Tillisch J, Brunken R, Marshall R, Schwaiger M, MandelkernM, Phelps M, et al. Reversibility of cardial wall-motion abnormalities predicted by positron tomography. N Engl J Med. 1986;314(14):884-8. 31. Maddahi J, Schelbert H, Brunken R, Di Carli M. Role of thallium-201 and PET imaging in evaluation of myocardial viability and management of patients with coronary artery disease and left ventricular dysfunction. J Nucl Med. 1994;35(4):707-15. 32. Marshall RC, Tillisch JH, Phelps ME, Huang SC, Carson R, Henze E, et al. Identification and differentiation of restingmyocardial ischemia inmanwith positron computed tomography, 18F-labeled fluorodeoxyglucose, andN-13 ammonia. Circulation. 1983;67(4):766-78. 33. Goldstein R, Mullani N, Wong W, Hartz RK, Hicks CH, Fuentes F, et al. Positron imaging of myocardial infarction with rubidium-82. J Nucl Med. 1986;27(12):1824-9. 34. Gould K, Goldstein R, Mullani N, Kirkeeide RL, Wong WH, Tewson TJ, et al. Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. VIII. Clinical feasibility of positron cardiac imaging without a cyclotron using generator-produced rubidium-82.; J Am Cardiol. 1986;7(4):775-89. 35. Goldstein RA. Rubidium-82 kinetics after coronary occlusion: temporal relation net myocardial accumulation and viability in open-chested dogs. J Nucl Med. 1986;27(9):1456-61. 36. Stankewicz MA, Mansour CS, Eisner RL, Churchwell KB, Williams BR, Sigman SR, et al. Myocardial viability assessment by PET: 82Rb defect washout does not predict the results of metabolic–perfusion mismatch. J Nucl Med. 2005;46(10):1602-9. 37. Sampson UK, Dorbala S, Limaye A, Di Carli MF. Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease. J Am Coll Cardiol. 2007;49(10):1052-8. 38. Knesaurek K, Machac J, Krynyckyi BR, Almeida OD. Comparison of 2- dimensional and 3-dimensional 82Rb myocardial perfusion PET imaging. J Nucl Med. 2003;44(8):1350-6. 39. Krivokapich J, Smith GT, Huang SC, Hoffman EJ, Ratib O, Phelps ME, et al. 13N ammonia myocardial imaging at rest and with exercise in normal volunteers: quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation. 1989;80(5):1328-37. 40. Van den Hoff J, Burchert W, Borner AR, Fricke H, Kuhnel G, Meyer GJ, et al. [1-(11)C] acetate as a quantitative perfusion tracer inmyocardial PET. J Nucl Med. 2001;42(8):1174-82. 41. PartingtonSL,KwongRY,DorbalaS.Multimodality imaging intheassessment of myocardial viability. Heart Fail Rev. 2011;16(4):381-95. 42. AchenbachS.CardiacCT:stateoftheart forthedetectionofcoronaryarterial stenosis. J Cardiovasc Comput Tomogr. 2007;1(1):3-20. 43. Brodoefel H, Klumpp B, Reimann A, Fenchel M, Heuschmid M, Miller S, et al. Sixty-four-MSCT in the characterization of porcine acute and subacute myocardialinfarction:determinationoftransmuralityincomparisontomagnetic resonance imaging and histopathology. Eur J Radiol. 2007;62(2):235-46. 44. Romero J, Xue X, Gonzalez W, Garcia MJ. CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease: a meta-analysisofprospectivetrials.JACCCardiovascImaging.2012;5(5):494-508. 45. Hammermeister KE, DeRouen TA, DodgeHT. Variables predictive of survival in patients with coronary disease: selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations. Circulation. 1979;59(3):421-30. 286